14 Trials, 26,000 People: What the Omega-3 Brain Research Actually Shows

From The NatureCity Podcast · 12:29

Show by Nature City

Last episode, we described the different types of research used for supplement ingredients, with one of the main points being this: not all research deserves the same weight. In this episode, we show an example of why this matters, using recent studies that gave very different answers on fish oil supplements and brain health.Carl Pradelli, CEO and Co-Founder of NatureCity, walks through four omega-3 brain studies and shows how much weight he believes each one deserves based on how it was designed. Subscribe for research-first supplement guidance. WHAT YOU'LL LEARNWhy the ADNI database study found an association, not proof that omega-3s may cause cognitive declineWhat a 2025 overview of 14 randomized trials and more than 26,000 adults foundHow DHA and vitamin D performed in a 12-month placebo-controlled trial of 360 older adultsWhy a two-year high-dose DHA trial may have come out neutralThe questions to ask before trusting any supplement headline, positive or negative Two omega-3 stories reached the public at almost the same time. One generated headlines suggesting omega-3 supplements might be associated with faster cognitive decline in older adults. The other came from a randomized, double-blind, placebo-controlled trial reporting cognitive benefits from DHA and vitamin D. This is the second part of Carl's series on what "scientifically studied" and "research-backed" really mean, and it helps explain why the two results don't necessarily cancel each other out.The concerning result came from an initiative known as ADNI, a research database that has followed adults over time, collecting cognitive testing results, brain imaging and other health information. Here’s the first important point: this was not a controlled trial designed to test omega-3 supplements.Researchers matched 273 adults who reported taking omega-3 supplements with 546 non-users and followed them for a median of about five years. The users showed faster declines on certain cognitive measures. The study did not randomly assign supplements, could not reliably separate fish oil formulations and lacked detailed dose and adherence data. The authors raised oxidized fish oil as a possible explanation, but the study never measured the oil's condition. That makes the finding an association worth investigating, not proof of cause.Randomized placebo-controlled evidence – believed to be the most reliable type of research – points in a different direction. A 2025 overview of nine systematic reviews, covering 14 randomized controlled trials and more than 26,000 people age 40 and older, found a small but statistically significant improvement on the Mini-Mental State Examination. Carl stresses the word “modest”, and we shouldn’t overstate the conclusion of this review.Separately, a new 12-month trial of 360 older adults found that both 1 gram of DHA a day and 800 IU of vitamin D a day improved cognitive scores compared with placebo, and the combination improved several measures more than either nutrient alone. Of the 360 participants, 355 completed the study, and adherence topped 90%.However, not every trial agrees. Another two-year study that gave high-dose DHA to older adults at increased risk for cognitive decline confirmed that DHA reached the central nervous system but found no significant difference in cognitive performance or brain volume. Carl explains why results vary: starting omega-3 levels, cognitive status, dose, EPA-to-DHA ratio, study length, genetics, diet, absorption, and the stage of cognitive aging all differ from study to study. No single study settles the question; the totality of the evidence does – and results will vary by individual.Carl also explains why checking a box that you take "omega-3s" on a survey tells researchers little without the amounts of EPA and DHA, the form, the dose, compliance, how well it was absorbed and whether it was protected from oxidation. That is why NatureCity pays close attention to these details in its TrueOmega-3, which pairs AlaskOmega fish oil, produced with a focus on purity, freshness and oxidation control, with the AquaCelle delivery system, studied in humans for improving EPA and DHA absorption compared with the same fish oil alone.So when you see a headline saying a supplement may help or harm your health, you should ask the same question about the research: How did they determine that?Carl and his wife, Beth, started NatureCity more than 25 years ago, and the company has served more than 500,000 Americans. This video is educational and is not medical advice. Talk with your doctor before starting or stopping a supplement. TIMESTAMPS 0:00 Conflicting Omega-3 Brain Headlines1:20 What the ADNI Fish Oil Study Missed3:15 14 Trials, 26,000 People: The Overview4:30 A New DHA and Vitamin D Trial Showed Benefits6:15 The Two-Year DHA Trial That Was Neutral7:30 Why Omega-3 Studies May Disagree8:45 Why "Fish Oil" Isn't One Thing10:00 Questions to Ask Every Headline Watch Part 1, what "scientifically…

More episodes of The NatureCity Podcast

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.